I assume Stupp would be in the FDA Advisory Committee given his prestige in the field of GBM, which I suppose is a good for facilitating the approval of DcVax.
Dr. Stupp coauthored with Linda Liau's colleague Timothy Cloughesy who is currently the principal investigator of the combo trial of Dcvax + keytruda. This is the only time that Stupp mentioned NWBO in disclosure. It would think that Dr. Stupp helped NWBO preparing the filing for approval or desging more phase 2 combo trials. Just my speculations.
Market Data 
Markets 
AI
